Baugh & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.01M | Sell |
54,520
-7,869
| -13% | -$921K | 3.1% | 10 |
|
|
2026
Q1 | $7.5M | Buy |
62,389
+1,144
| +2% | +$132K | 3.24% | 12 |
|
|
2025
Q4 | $5.93M | Sell |
61,245
-1,761
| -3% | -$165K | 2.92% | 13 |
|
|
2025
Q3 | $4.83M | Sell |
63,006
-1,219
| -2% | -$100K | 2.4% | 20 |
|
|
2025
Q2 | $4.67M | Buy |
64,225
+3,328
| +5% | +$265K | 2.43% | 18 |
|
|
2025
Q1 | $5.2M | Buy |
60,897
+10,094
| +20% | +$942K | 2.63% | 18 |
|
|
2024
Q4 | $4.89M | Sell |
50,803
-20
| -0% | -$2.06K | 2.53% | 19 |
|
|
2024
Q3 | $5.53M | Buy |
50,823
+4,541
| +10% | +$539K | 2.85% | 14 |
|
|
2024
Q2 | $5.99M | Sell |
46,282
-2,142
| -4% | -$276K | 3.11% | 11 |
|
|
2024
Q1 | $6.39M | Buy |
48,424
+348
| +0.7% | +$42.9K | 3.4% | 9 |
|
|
2023
Q4 | $5.24M | Sell |
48,076
-668
| -1% | -$69.3K | 3.01% | 13 |
|
|
2023
Q3 | $5.02M | Sell |
48,744
-220
| -0.4% | -$23.7K | 3.14% | 11 |
|
|
2023
Q2 | $5.65M | Buy |
48,964
+785
| +2% | +$89.1K | 3.4% | 10 |
|
|
2023
Q1 | $5.22M | Sell |
48,179
-1,076
| -2% | -$116K | 3.33% | 10 |
|
|
2022
Q4 | $5.46M | Sell |
49,255
-75
| -0.2% | -$7.67K | 3.54% | 10 |
|
|
2022
Q3 | $4.25M | Sell |
49,330
-60
| -0.1% | -$5.36K | 3.01% | 16 |
|
|
2022
Q2 | $4.5M | Sell |
49,390
-540
| -1% | -$47.9K | 3.03% | 12 |
|
|
2022
Q1 | $4.1M | Sell |
49,930
-160
| -0.3% | -$12.6K | 2.41% | 22 |
|
|
2021
Q4 | $3.84M | Buy |
50,090
+5
| +0% | +$398 | 2.12% | 23 |
|
|
2021
Q3 | $3.76M | Sell |
50,085
-29
| -0.1% | -$2.21K | 2.3% | 21 |
|
|
2021
Q2 | $3.9M | Sell |
50,114
-2,888
| -5% | -$215K | 2.42% | 21 |
|
|
2021
Q1 | $3.9M | Sell |
53,002
-6
| -0% | -$443 | 2.57% | 19 |
|
|
2020
Q4 | $4.14M | Sell |
53,008
-650
| -1% | -$49.7K | 2.95% | 13 |
|
|
2020
Q3 | $4.25M | Sell |
53,658
-676
| -1% | -$53K | 3.33% | 8 |
|
|
2020
Q2 | $4.01M | Buy |
54,334
+3,786
| +7% | +$285K | 3.2% | 9 |
|
|
2020
Q1 | $3.71M | Sell |
50,548
-1,488
| -3% | -$117K | 3.59% | 7 |
|
|
2019
Q4 | $4.52M | Sell |
52,036
-531
| -1% | -$43.6K | 3.3% | 10 |
|
|
2019
Q3 | $4.22M | Sell |
52,567
-209
| -0.4% | -$16.8K | 3.27% | 8 |
|
|
2019
Q2 | $4.22M | Sell |
52,776
-362
| -0.7% | -$27.7K | 3.35% | 6 |
|
|
2019
Q1 | $4.22M | Sell |
53,138
-393
| -0.7% | -$29.4K | 3.38% | 7 |
|
|
2018
Q4 | $3.9M | Sell |
53,531
-87
| -0.2% | -$6.14K | 3.36% | 6 |
|
|
2018
Q3 | $3.63M | Sell |
53,618
-629
| -1% | -$40.1K | 2.9% | 14 |
|
|
2018
Q2 | $3.14M | Sell |
54,247
-4,934
| -8% | -$278K | 2.74% | 18 |
|
|
2018
Q1 | $3.08M | Buy |
+59,181
| New | +$3.2M | 2.48% | 25 |
|
Other funds holding MRK
ECSS
ATO
Baugh & Associates's MRK Position: Q2 2026 in Review
Baugh & Associates reduced its Merck (MRK) stake by 13% in Q2 2026, selling an estimated $921K and leaving 54,520 shares worth $7.01M. The position accounts for 3.1% of the portfolio, ranked #10.
Baugh & Associates first reported a position in MRK in Q1 2018 and has held it in 34 quarters since. The position peaked at $7.5M in Q1 2026. 1,617 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Baugh & Associates held 54,520 shares of Merck worth $7.01M as of Q2 2026.
- Baugh & Associates sold 7,869 Merck shares in Q2 2026, an estimated $921K.
- Merck made up 3.1% of Baugh & Associates's portfolio in Q2 2026, its #10 holding.
- Baugh & Associates first reported a position in Merck in Q1 2018 and has held it in 34 quarters since.
- Baugh & Associates's Merck position peaked at $7.5M in Q1 2026.
- 1,617 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Baugh & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.